nodes	percent_of_prediction	percent_of_DWPC	metapath
Pefloxacin—TOP2A—Teniposide—lung cancer	0.48	0.526	CbGbCtD
Pefloxacin—TOP2A—Etoposide—lung cancer	0.212	0.232	CbGbCtD
Pefloxacin—TOP2A—Doxorubicin—lung cancer	0.144	0.158	CbGbCtD
Pefloxacin—CYP1A2—Erlotinib—lung cancer	0.0447	0.049	CbGbCtD
Pefloxacin—CYP1A2—Etoposide—lung cancer	0.0323	0.0355	CbGbCtD
Pefloxacin—TOP2A—Docetaxel—Paclitaxel—lung cancer	0.000968	0.097	CbGdCrCtD
Pefloxacin—TOP2A—Irinotecan—Topotecan—lung cancer	0.000829	0.083	CbGdCrCtD
Pefloxacin—Gatifloxacin—ALB—lung cancer	0.000808	0.287	CrCbGaD
Pefloxacin—Norfloxacin—CYP2A6—lung cancer	0.000771	0.274	CrCbGaD
Pefloxacin—TOP2A—Erlotinib—Gefitinib—lung cancer	0.000723	0.0724	CbGdCrCtD
Pefloxacin—TOP2A—Topotecan—Irinotecan—lung cancer	0.000689	0.069	CbGdCrCtD
Pefloxacin—TOP2A—Etoposide—Teniposide—lung cancer	0.000684	0.0686	CbGdCrCtD
Pefloxacin—TOP2A—Vindesine—Vinorelbine—lung cancer	0.000616	0.0617	CbGdCrCtD
Pefloxacin—Norfloxacin—CYP1A1—lung cancer	0.00054	0.192	CrCbGaD
Pefloxacin—TOP2A—Podofilox—Teniposide—lung cancer	0.000522	0.0523	CbGdCrCtD
Pefloxacin—TOP2A—Vindesine—Vinblastine—lung cancer	0.000492	0.0493	CbGdCrCtD
Pefloxacin—TOP2A—Methotrexate—Pemetrexed—lung cancer	0.000491	0.0492	CbGdCrCtD
Pefloxacin—TOP2A—Paclitaxel—Docetaxel—lung cancer	0.000483	0.0484	CbGdCrCtD
Pefloxacin—TOP2A—Afatinib—Gefitinib—lung cancer	0.000473	0.0474	CbGdCrCtD
Pefloxacin—TOP2A—Gefitinib—Erlotinib—lung cancer	0.000464	0.0465	CbGdCrCtD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—UGT1A1—lung cancer	0.000419	0.00556	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—AHR—lung cancer	0.000407	0.00541	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—AHR—lung cancer	0.000407	0.00541	CbGpPWpGaD
Pefloxacin—CYP1A2—Xenobiotics—CYP1A1—lung cancer	0.000406	0.00539	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—NFE2L2—lung cancer	0.000397	0.00527	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—NFE2L2—lung cancer	0.000397	0.00527	CbGpPWpGaD
Pefloxacin—CYP1A2—Tamoxifen metabolism—CYP1A1—lung cancer	0.00039	0.00519	CbGpPWpGaD
Pefloxacin—CYP1A2—Phase II conjugation—GSTM2—lung cancer	0.000387	0.00514	CbGpPWpGaD
Pefloxacin—CYP1A2—Phase II conjugation—CNDP2—lung cancer	0.000387	0.00514	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ANXA1—lung cancer	0.000386	0.00514	CbGpPWpGaD
Pefloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP2A7—lung cancer	0.000385	0.00512	CbGpPWpGaD
Pefloxacin—TOP2A—Gastric Cancer Network 2—TP53—lung cancer	0.000385	0.00512	CbGpPWpGaD
Pefloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—lung cancer	0.00037	0.00491	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—APP—lung cancer	0.000366	0.00487	CbGpPWpGaD
Pefloxacin—TOP2A—Mitotic G1-G1/S phases—TYMS—lung cancer	0.000358	0.00475	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—HPGDS—lung cancer	0.000356	0.00473	CbGpPWpGaD
Pefloxacin—Levofloxacin—ABCB1—lung cancer	0.000354	0.126	CrCbGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—JUNB—lung cancer	0.000347	0.00461	CbGpPWpGaD
Pefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—RB1—lung cancer	0.000345	0.00458	CbGpPWpGaD
Pefloxacin—Ciprofloxacin—ABCB1—lung cancer	0.000342	0.121	CrCbGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—GCLC—lung cancer	0.000341	0.00454	CbGpPWpGaD
Pefloxacin—CYP1A2—Arachidonic acid metabolism—HPGDS—lung cancer	0.000333	0.00442	CbGpPWpGaD
Pefloxacin—TOP2A—Vincristine—Vinorelbine—lung cancer	0.000332	0.0333	CbGdCrCtD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—STK11—lung cancer	0.000315	0.00419	CbGpPWpGaD
Pefloxacin—CYP1A2—Phase II conjugation—GSTA3—lung cancer	0.000312	0.00414	CbGpPWpGaD
Pefloxacin—TOP2A—Vinorelbine—Vinblastine—lung cancer	0.000311	0.0311	CbGdCrCtD
Pefloxacin—TOP2A—Teniposide—Etoposide—lung cancer	0.00031	0.0311	CbGdCrCtD
Pefloxacin—TOP2A—Podofilox—Etoposide—lung cancer	0.00031	0.0311	CbGdCrCtD
Pefloxacin—CYP1A2—Estrogen Receptor Pathway—JUN—lung cancer	0.000307	0.00408	CbGpPWpGaD
Pefloxacin—CYP1A2—Melatonin metabolism and effects—CYP1A1—lung cancer	0.000302	0.00401	CbGpPWpGaD
Pefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MDM2—lung cancer	0.000294	0.0039	CbGpPWpGaD
Pefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—RAF1—lung cancer	0.000293	0.00389	CbGpPWpGaD
Pefloxacin—CYP1A2—Tryptophan metabolism—CYP2E1—lung cancer	0.00029	0.00386	CbGpPWpGaD
Pefloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—lung cancer	0.000289	0.00383	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—NQO1—lung cancer	0.000287	0.00381	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—NQO1—lung cancer	0.000287	0.00381	CbGpPWpGaD
Pefloxacin—CYP1A2—Phase II conjugation—GSTA4—lung cancer	0.000285	0.00379	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUNB—lung cancer	0.000285	0.00378	CbGpPWpGaD
Pefloxacin—CYP1A2—Phase II conjugation—GSTA2—lung cancer	0.000278	0.00369	CbGpPWpGaD
Pefloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2A6—lung cancer	0.000276	0.00367	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ABCB1—lung cancer	0.000276	0.00367	CbGpPWpGaD
Pefloxacin—TOP2A—Circadian rythm related genes—AVP—lung cancer	0.000274	0.00363	CbGpPWpGaD
Pefloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP2A6—lung cancer	0.000272	0.00362	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TYMS—lung cancer	0.000271	0.0036	CbGpPWpGaD
Pefloxacin—CYP1A2—Phase II conjugation—GSTA1—lung cancer	0.000268	0.00356	CbGpPWpGaD
Pefloxacin—TOP2A—Vinblastine—Vinorelbine—lung cancer	0.000267	0.0268	CbGdCrCtD
Pefloxacin—CYP1A2—Estrogen Receptor Pathway—STAT3—lung cancer	0.000266	0.00353	CbGpPWpGaD
Pefloxacin—TOP2A—Vincristine—Vinblastine—lung cancer	0.000266	0.0266	CbGdCrCtD
Pefloxacin—TOP2A—Circadian rythm related genes—TYMS—lung cancer	0.00026	0.00346	CbGpPWpGaD
Pefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—lung cancer	0.000256	0.0034	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—FOXM1—lung cancer	0.000252	0.00334	CbGpPWpGaD
Pefloxacin—CYP1A2—Phase II conjugation—UGT1A1—lung cancer	0.000249	0.00331	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FASLG—lung cancer	0.000249	0.00331	CbGpPWpGaD
Pefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1A—lung cancer	0.000248	0.00329	CbGpPWpGaD
Pefloxacin—TOP2A—Mitotic G1-G1/S phases—RB1—lung cancer	0.000243	0.00322	CbGpPWpGaD
Pefloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2E1—lung cancer	0.000235	0.00312	CbGpPWpGaD
Pefloxacin—CYP1A2—Tryptophan metabolism—CAT—lung cancer	0.000233	0.00309	CbGpPWpGaD
Pefloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP2E1—lung cancer	0.000232	0.00308	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FGFR1—lung cancer	0.000229	0.00305	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—GSTM2—lung cancer	0.000226	0.00301	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—CNDP2—lung cancer	0.000226	0.00301	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—FOXM1—lung cancer	0.000225	0.00299	CbGpPWpGaD
Pefloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP2A6—lung cancer	0.000224	0.00297	CbGpPWpGaD
Pefloxacin—CYP1A2—Metapathway biotransformation—GSTM2—lung cancer	0.000223	0.00296	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—lung cancer	0.000221	0.00294	CbGpPWpGaD
Pefloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN2A—lung cancer	0.000213	0.00283	CbGpPWpGaD
Pefloxacin—CYP1A2—Phase II conjugation—HPGDS—lung cancer	0.000212	0.00282	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—PPP2R1B—lung cancer	0.000209	0.00277	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—lung cancer	0.000208	0.00277	CbGpPWpGaD
Pefloxacin—CYP1A2—Tryptophan metabolism—CYP1A1—lung cancer	0.000208	0.00277	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—lung cancer	0.000208	0.00277	CbGpPWpGaD
Pefloxacin—CYP1A2—Phase II conjugation—GSTT1—lung cancer	0.000205	0.00273	CbGpPWpGaD
Pefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MYC—lung cancer	0.000205	0.00273	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—CYP2A7—lung cancer	0.000205	0.00272	CbGpPWpGaD
Pefloxacin—CYP1A2—Phase II conjugation—GCLC—lung cancer	0.000203	0.0027	CbGpPWpGaD
Pefloxacin—CYP1A2—Metapathway biotransformation—CYP2A7—lung cancer	0.000202	0.00268	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—LMNA—lung cancer	0.000199	0.00264	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—APC—lung cancer	0.000199	0.00264	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGF—lung cancer	0.000197	0.00261	CbGpPWpGaD
Pefloxacin—CYP1A2—Arachidonic acid metabolism—CYP1A1—lung cancer	0.000195	0.00259	CbGpPWpGaD
Pefloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP2E1—lung cancer	0.00019	0.00253	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—PPP2R1B—lung cancer	0.000187	0.00248	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP8—lung cancer	0.000185	0.00246	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CREBBP—lung cancer	0.000184	0.00245	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—GSTA3—lung cancer	0.000182	0.00242	CbGpPWpGaD
Pefloxacin—TOP2A—Mitotic G1-G1/S phases—CCND1—lung cancer	0.00018	0.00239	CbGpPWpGaD
Pefloxacin—CYP1A2—Metapathway biotransformation—GSTA3—lung cancer	0.00018	0.00239	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—LMNA—lung cancer	0.000178	0.00236	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAP2K1—lung cancer	0.000176	0.00234	CbGpPWpGaD
Pefloxacin—TOP2A—Cytarabine—Gemcitabine—lung cancer	0.000175	0.0175	CbGdCrCtD
Pefloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN1A—lung cancer	0.000174	0.00232	CbGpPWpGaD
Pefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—lung cancer	0.000169	0.00224	CbGpPWpGaD
Pefloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—lung cancer	0.000169	0.00224	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—GSTA4—lung cancer	0.000167	0.00222	CbGpPWpGaD
Pefloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—lung cancer	0.000166	0.00221	CbGpPWpGaD
Pefloxacin—CYP1A2—Metapathway biotransformation—GSTA4—lung cancer	0.000164	0.00219	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—GSTA2—lung cancer	0.000163	0.00216	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—GSTA1—lung cancer	0.000157	0.00208	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MDM2—lung cancer	0.000157	0.00208	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—RAF1—lung cancer	0.000156	0.00207	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—lung cancer	0.000154	0.00205	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—lung cancer	0.000151	0.00201	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—RB1—lung cancer	0.000151	0.002	CbGpPWpGaD
Pefloxacin—TOP2A—Daunorubicin—Doxorubicin—lung cancer	0.00015	0.015	CbGdCrCtD
Pefloxacin—TOP2A—Idarubicin—Doxorubicin—lung cancer	0.00015	0.015	CbGdCrCtD
Pefloxacin—TOP2A—Epirubicin—Doxorubicin—lung cancer	0.00015	0.015	CbGdCrCtD
Pefloxacin—CYP1A2—Metapathway biotransformation—AKR1C1—lung cancer	0.000148	0.00197	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—UGT1A1—lung cancer	0.000146	0.00194	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—MAP2K1—lung cancer	0.000145	0.00192	CbGpPWpGaD
Pefloxacin—TOP2A—Mitotic G1-G1/S phases—MYC—lung cancer	0.000144	0.00192	CbGpPWpGaD
Pefloxacin—CYP1A2—Metapathway biotransformation—UGT1A1—lung cancer	0.000144	0.00191	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—COL4A3BP—lung cancer	0.000143	0.00191	CbGpPWpGaD
Pefloxacin—CYP1A2—Phase II conjugation—GSTP1—lung cancer	0.000142	0.00189	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—lung cancer	0.00014	0.00186	CbGpPWpGaD
Pefloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—lung cancer	0.000137	0.00182	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—lung cancer	0.000136	0.00181	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—JUN—lung cancer	0.000136	0.00181	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	0.000132	0.00175	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	0.000132	0.00175	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—TYMS—lung cancer	0.000131	0.00174	CbGpPWpGaD
Pefloxacin—CYP1A2—Phase II conjugation—GSTM1—lung cancer	0.000131	0.00174	CbGpPWpGaD
Pefloxacin—TOP2A—Circadian rythm related genes—JUN—lung cancer	0.000131	0.00174	CbGpPWpGaD
Pefloxacin—CYP1A2—Tryptophan metabolism—MDM2—lung cancer	0.000129	0.00171	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—lung cancer	0.000128	0.0017	CbGpPWpGaD
Pefloxacin—TOP2A—Circadian rythm related genes—PTEN—lung cancer	0.000126	0.00168	CbGpPWpGaD
Pefloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	0.000126	0.00167	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	0.000126	0.00167	CbGpPWpGaD
Pefloxacin—TOP2A—Azacitidine—Gemcitabine—lung cancer	0.000125	0.0125	CbGdCrCtD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—lung cancer	0.000124	0.00165	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—HPGDS—lung cancer	0.000124	0.00165	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	0.000122	0.00162	CbGpPWpGaD
Pefloxacin—TOP2A—Circadian rythm related genes—EP300—lung cancer	0.000121	0.0016	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—GSTT1—lung cancer	0.00012	0.0016	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	0.000119	0.00158	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—GCLC—lung cancer	0.000119	0.00158	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—CYP2A6—lung cancer	0.000119	0.00158	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—BIRC5—lung cancer	0.000118	0.00157	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—TYMS—lung cancer	0.000117	0.00156	CbGpPWpGaD
Pefloxacin—CYP1A2—Arachidonic acid metabolism—PTGS2—lung cancer	0.000116	0.00154	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—lung cancer	0.000115	0.00153	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	0.000113	0.0015	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—lung cancer	0.000112	0.00149	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	0.000109	0.00145	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PLBD1—lung cancer	0.000109	0.00144	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—lung cancer	0.000108	0.00144	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	0.000107	0.00142	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—BIRC5—lung cancer	0.000105	0.0014	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—lung cancer	0.000103	0.00137	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—EP300—lung cancer	0.000103	0.00137	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—TERT—lung cancer	0.000102	0.00136	CbGpPWpGaD
Pefloxacin—CYP1A2—Phase 1 - Functionalization of compounds—POMC—lung cancer	0.000102	0.00135	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	0.000101	0.00134	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—CYP2E1—lung cancer	0.000101	0.00134	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—SRC—lung cancer	0.0001	0.00133	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—lung cancer	0.0001	0.00133	CbGpPWpGaD
Pefloxacin—CYP1A2—Metapathway biotransformation—CYP2E1—lung cancer	9.97e-05	0.00132	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—lung cancer	9.77e-05	0.0013	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—lung cancer	9.65e-05	0.00128	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	9.29e-05	0.00123	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	8.99e-05	0.00119	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—lung cancer	8.99e-05	0.00119	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—RB1—lung cancer	8.89e-05	0.00118	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—lung cancer	8.79e-05	0.00117	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—lung cancer	8.79e-05	0.00117	CbGpPWpGaD
Pefloxacin—TOP2A—Circadian rythm related genes—TP53—lung cancer	8.63e-05	0.00115	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—MTMR3—lung cancer	8.45e-05	0.00112	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—GSTP1—lung cancer	8.33e-05	0.00111	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—lung cancer	8.3e-05	0.0011	CbGpPWpGaD
Pefloxacin—CYP1A2—Metapathway biotransformation—GSTP1—lung cancer	8.22e-05	0.00109	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—RB1—lung cancer	7.95e-05	0.00106	CbGpPWpGaD
Pefloxacin—TOP2A—Circadian rythm related genes—IL6—lung cancer	7.9e-05	0.00105	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2A—lung cancer	7.82e-05	0.00104	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—GSTM1—lung cancer	7.66e-05	0.00102	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	7.59e-05	0.00101	CbGpPWpGaD
Pefloxacin—CYP1A2—Metapathway biotransformation—GSTM1—lung cancer	7.55e-05	0.001	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—CYP1A1—lung cancer	7.26e-05	0.000965	CbGpPWpGaD
Pefloxacin—CYP1A2—Metapathway biotransformation—CYP1A1—lung cancer	7.16e-05	0.000951	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—lung cancer	7.06e-05	0.000938	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—CDKN2A—lung cancer	6.99e-05	0.000929	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—MDM2—lung cancer	6.78e-05	0.000901	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—CCND1—lung cancer	6.61e-05	0.000878	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1A—lung cancer	6.39e-05	0.000849	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—COL4A3BP—lung cancer	6.39e-05	0.000848	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—AZIN2—lung cancer	6.39e-05	0.000848	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—EP300—lung cancer	6.08e-05	0.000808	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	5.95e-05	0.000791	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—CCND1—lung cancer	5.91e-05	0.000785	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	5.77e-05	0.000766	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—CDKN1A—lung cancer	5.71e-05	0.000759	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—MAPK3—lung cancer	5.45e-05	0.000724	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—EP300—lung cancer	5.44e-05	0.000722	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—ATP5H—lung cancer	5.43e-05	0.000721	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—POMC—lung cancer	5.41e-05	0.000719	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—MYC—lung cancer	5.3e-05	0.000704	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	4.99e-05	0.000663	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—MAPK3—lung cancer	4.87e-05	0.000647	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—PLBD1—lung cancer	4.84e-05	0.000643	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	4.76e-05	0.000632	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—MYC—lung cancer	4.74e-05	0.00063	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—HSD17B10—lung cancer	4.43e-05	0.000588	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—CKB—lung cancer	4.11e-05	0.000547	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—TP53—lung cancer	3.89e-05	0.000517	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—CNDP2—lung cancer	3.87e-05	0.000514	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—GSTM2—lung cancer	3.87e-05	0.000514	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—MTMR3—lung cancer	3.76e-05	0.0005	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—PGAM1—lung cancer	3.67e-05	0.000487	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—CYP2A7—lung cancer	3.5e-05	0.000465	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—SDC4—lung cancer	3.42e-05	0.000455	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—GSTA3—lung cancer	3.12e-05	0.000414	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—RRM1—lung cancer	3.12e-05	0.000414	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—B4GALT5—lung cancer	2.93e-05	0.00039	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—GSTA4—lung cancer	2.85e-05	0.000379	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	2.79e-05	0.00037	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—GSTA2—lung cancer	2.78e-05	0.000369	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—GSTA1—lung cancer	2.68e-05	0.000356	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—ABCC3—lung cancer	2.65e-05	0.000352	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—AKR1C1—lung cancer	2.57e-05	0.000341	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—UGT1A1—lung cancer	2.49e-05	0.000331	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—GNG11—lung cancer	2.4e-05	0.000319	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	2.39e-05	0.000318	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—ALDOA—lung cancer	2.29e-05	0.000304	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—NCOA3—lung cancer	2.22e-05	0.000295	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	2.18e-05	0.00029	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—ADCY1—lung cancer	2.16e-05	0.000287	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—ABCG2—lung cancer	2.16e-05	0.000287	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—HPGDS—lung cancer	2.12e-05	0.000282	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—ENO2—lung cancer	2.12e-05	0.000282	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—PPP2R1B—lung cancer	2.11e-05	0.00028	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—POMC—lung cancer	2.08e-05	0.000276	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—GSTT1—lung cancer	2.06e-05	0.000273	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—CYP2A6—lung cancer	2.03e-05	0.00027	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—GCLC—lung cancer	2.03e-05	0.00027	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	2.02e-05	0.000269	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—ENO1—lung cancer	1.93e-05	0.000256	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.92e-05	0.000255	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.89e-05	0.000252	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—CYP2E1—lung cancer	1.73e-05	0.00023	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—NQO1—lung cancer	1.71e-05	0.000227	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.67e-05	0.000222	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.66e-05	0.00022	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—STK11—lung cancer	1.54e-05	0.000205	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.45e-05	0.000192	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—GSTP1—lung cancer	1.43e-05	0.000189	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—CAT—lung cancer	1.39e-05	0.000184	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.38e-05	0.000183	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—ABCB1—lung cancer	1.35e-05	0.000179	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—TYMS—lung cancer	1.32e-05	0.000176	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—GSTM1—lung cancer	1.31e-05	0.000174	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—CYP1A1—lung cancer	1.24e-05	0.000165	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—ERCC2—lung cancer	1.23e-05	0.000164	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—APOA1—lung cancer	1.07e-05	0.000142	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.02e-05	0.000136	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—PIK3CG—lung cancer	9.72e-06	0.000129	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—POMC—lung cancer	9.26e-06	0.000123	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—CREBBP—lung cancer	9.02e-06	0.00012	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—PIK3CD—lung cancer	8.55e-06	0.000114	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—ALB—lung cancer	8.44e-06	0.000112	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—PIK3CB—lung cancer	7.45e-06	9.9e-05	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—PTGS2—lung cancer	7.38e-06	9.81e-05	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—PTEN—lung cancer	6.44e-06	8.55e-05	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—EP300—lung cancer	6.14e-06	8.16e-05	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—PIK3CA—lung cancer	4.54e-06	6.04e-05	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—AKT1—lung cancer	3.71e-06	4.93e-05	CbGpPWpGaD
